Roche's Tecentriq boosts survival in triple-negative breast cancer

Saturday, October 20, 2018 - 09:50 in Health & Medicine

An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.

Read the whole article on Reuters:Science

More from Reuters:Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net